skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Stephanie


+3 year(s) experience

Stephanie Yip
Analyst Stephanie Yip provides in-depth insights focusing on CNS and rare disease markets. She liaises with key opinion leaders, analyzes treatment landscapes and tracks market moving events to build robust forecasts.

Since joining Datamonitor Healthcare’s CNS and Rare Diseases team in 2017, Stephanie has produced content on epilepsy, bipolar disorder and schizophrenia. She will further expand her coverage to include pulmonary hypertension, migraine and multiple sclerosis.

Prior to Informa, Stephanie gained experience as an editorial assistant in scientific publishing. She graduated from Imperial College London with a Biomedical Science degree.

As an analyst, Stephanie’s greatest achievement has been contextualizing key events through her understanding of market dynamics and integrating this knowledge into forecasts for a variety of diseases.

Analyst Articles

Articles by Stephanie

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Datamonitor Healthcare: 医療用医薬...

    Top 10 Best-Selling Drugs of 2019

    In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

    Topic Drug Review Diseases